- Investing Ideas
- Swedish Pharmaceuticals & Biotech High Insider Buying
Swedish Pharmaceuticals & Biotech High Insider Buying
Results
12
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
12 companies
Swedish Orphan Biovitrum
Market Cap: SEK 137.8b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 398.60
7D
-4.6%
1Y
42.8%
Camurus
Market Cap: SEK 32.1b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 537.50
7D
-4.7%
1Y
-8.9%
AddLife
Market Cap: SEK 18.5b
Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 151.90
7D
-7.9%
1Y
-11.1%
MedCap
Market Cap: SEK 7.2b
A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout.
MCAP
SEK 478.20
7D
-6.1%
1Y
15.5%
Swedencare
Market Cap: SEK 4.3b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 27.00
7D
-3.7%
1Y
-28.2%
Devyser Diagnostics
Market Cap: SEK 1.6b
Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.
DVYSR
SEK 95.90
7D
10.4%
1Y
0.4%
Genovis AB (publ.)
Market Cap: SEK 1.3b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 20.05
7D
0.5%
1Y
-14.9%
Corline Biomedical
Market Cap: SEK 409.8m
Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications in Sweden.
CLBIO
SEK 16.00
7D
0%
1Y
48.8%
Mendus
Market Cap: SEK 311.0m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 5.07
7D
-1.9%
1Y
2.4%
Promimic
Market Cap: SEK 204.0m
Manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets.
PRO
SEK 10.80
7D
-5.3%
1Y
-61.2%
Alzinova
Market Cap: SEK 68.8m
A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.
ALZ
SEK 0.44
7D
-23.4%
1Y
-76.6%
PharmaLundensis
Market Cap: SEK 15.3m
PharmaLundensis AB operates as a pharmaceutical company.
PHAL
SEK 0.36
7D
0%
1Y
-44.6%